CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-308058 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 17, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
120,000
Total Value
$4,370,511.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jul 15, 2026 | Exercise/Conversion | 15,833 | $19.26 | $304,943.58 | 31,963 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 15, 2026 | Exercise/Conversion | 24,167 | $23.06 | $557,291.02 | 56,130 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 15, 2026 | Sale | 7,919 | $86.78 | $687,179.14 | 48,211 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 15, 2026 | Sale | 28,460 | $87.89 | $2,501,244.10 | 19,751 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 15, 2026 | Sale | 3,520 | $88.30 | $310,821.63 | 16,231 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 15, 2026 | Sale | 101 | $89.43 | $9,032.25 | 16,130 | Direct | โ | View Details | |
Chief Financial Officer | Stock option (right to buy) | Derivative | Jul 15, 2026 | Exercise/Conversion | 15,833 | $0.00 | $0.00 | 4,167 | Direct | โ | View Details | |
Chief Financial Officer | Stock option (right to buy) | Derivative | Jul 15, 2026 | Exercise/Conversion | 24,167 | $0.00 | $0.00 | 175,833 | Direct | โ | View Details |